Cargando…
COVID‐19 restrictions and the incidence and prevalence of prescription opioid use in Australia – a nationwide study
The COVID‐19 pandemic has disrupted seeking and delivery of healthcare. Different Australian jurisdictions implemented different COVID‐19 restrictions. We used Australian national pharmacy dispensing data to conduct interrupted time series analyses to examine the incidence and prevalence of opioid d...
Autores principales: | Jung, Monica, Lukose, Dickson, Nielsen, Suzanne, Bell, J. Simon, Webb, Geoffrey I., Ilomäki, Jenni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874526/ https://www.ncbi.nlm.nih.gov/pubmed/36301837 http://dx.doi.org/10.1111/bcp.15577 |
Ejemplares similares
-
Did Australia's COVID-19 Restrictions Impact Statin Incidence, Prevalence or Adherence?
por: Livori, Adam C., et al.
Publicado: (2023) -
Cohort profile: Using primary care data to understand Opioid Prescribing, Policy Impacts and Clinical Outcomes (OPPICO) in Victoria, Australia.
por: Nielsen, Suzanne, et al.
Publicado: (2023) -
Hip fracture incidence and post-fracture mortality in Victoria, Australia: a state-wide cohort study
por: Leung, Miriam T. Y., et al.
Publicado: (2023) -
Correction to: Hip fracture incidence and post-fracture mortality in Victoria, Australia: a state-wide cohort study
por: Leung, Miriam T. Y., et al.
Publicado: (2023) -
Harms of prescription opioid use in the United States
por: Imtiaz, Sameer, et al.
Publicado: (2014)